Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Sacit Bulent Omay"'
Autor:
Christopher S. Hong, Sacit Bulent Omay
Publikováno v:
Current Oncology, Vol 29, Iss 3, Pp 1408-1421 (2022)
Craniopharyngiomas are rare, benign primary brain tumors that arise from remnants of the craniopharyngeal duct epithelium within the sellar and suprasellar region. Despite their benign biology, they may cause significant morbidity, secondary to invol
Externí odkaz:
https://doaj.org/article/952e9ff9d89d481eb9680f09a5abd428
Autor:
Christopher S. Hong, Aladine A. Elsamadicy, Adeniyi Fisayo, Silvio E. Inzucchi, Pallavi P. Gopal, Eugenia M. Vining, E. Zeynep Erson-Omay, Sacit Bulent Omay
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Granular cell tumors of the pituitary belong to a rare family of neoplasms, arising from the posterior pituitary gland. Although considered benign, they may cause significant morbidity and residual disease after resection can lead to poor clinical ou
Externí odkaz:
https://doaj.org/article/94c5af30f1824fb198d774373bd5ae74
Autor:
Christopher S. Hong, Edwin Partovi, James Clune, Anita Huttner, Henry S. Park, Sacit Bulent Omay
Publikováno v:
Case Reports in Genetics, Vol 2021 (2021)
Intracranial undifferentiated pleomorphic sarcoma remains a rare pathology within the sarcoma literature that may arise primarily or secondary after radiation therapy. Despite first-line treatment with maximal surgical resection, followed by nonstand
Externí odkaz:
https://doaj.org/article/4de6ea74f76042b2a43df6fb2dd91f66
Autor:
Christopher S. Hong, Ramana Gorrepati, Adam J. Kundishora, Aladine A. Elsamadicy, Patricia R. Peter, Eyiyemisi C. Damisah, R. Peter Manes, Sacit Bulent Omay
Publikováno v:
Frontiers in Surgery, Vol 7 (2020)
Seizures in patients with pituitary pathology are uncommon and typically secondary to electrolyte disturbances. Rarely, seizures have been described from mass effect related to large prolactinomas undergoing medical treatment. We describe a 54 year-o
Externí odkaz:
https://doaj.org/article/867ba06fe29540cbb8ba90862890dc09
Autor:
Thuy T. Tran, Chetan K. Rane, Christopher R. Zito, Sarah A. Weiss, Shlomit Jessel, Liliana Lucca, Benjamin Y. Lu, Victor O. Oria, Adebowale Adeniran, Veronica L. Chiang, Sacit Bulent Omay, David A. Hafler, Harriet M. Kluger, Lucia B. Jilaveanu
Publikováno v:
Cancers, Vol 13, Iss 5, p 1049 (2021)
Little is known about the subcellular localization and function of programmed cell death 4 (PDCD4) in melanoma. Our past studies suggest PDCD4 interacts with Pleckstrin Homology Domain Containing A5 (PLEKHA5) to influence melanoma brain metastasis ou
Externí odkaz:
https://doaj.org/article/b52fe8e973dd414d9aae12faeaa4e03e
Autor:
Joanna K. Tabor, Joseph O’Brien, Sagar Vasandani, Shaurey Vetsa, Haoyi Lei, Muhammad I. Jalal, Neelan J. Marianayagam, Lan Jin, Miguel Millares Chavez, Joseph Haynes, Alper Dincer, Kanat Yalcin, Stephanie M. Aguilera, Sacit Bulent Omay, Ketu Mishra-Gorur, Declan McGuone, Saul F. Morales-Valero, Robert K. Fulbright, Murat Gunel, E. Zeynep Erson-Omay, Jennifer Moliterno
Publikováno v:
Journal of Neurosurgery. :1-9
OBJECTIVE Mutations in NF2 are the most common somatic driver mutation in sporadic meningiomas. NF2 mutant meningiomas preferentially arise along the cerebral convexities—however, they can also be found in the posterior fossa. The authors investiga
Autor:
Darpan Kayastha, Daniel Wiznia, R. Peter Manes, Sacit Bulent Omay, Tawfiq Khoury, Ryan Rimmer
Publikováno v:
International Forum of Allergy & Rhinology.
Publikováno v:
Journal of Neurosurgery: Case Lessons. 5
BACKGROUND Superimposed intracranial infection is an uncommon but clinically significant complication in patients with active coronavirus disease 2019 (COVID-19), particularly in those with predisposing immunocompromising conditions. OBSERVATIONS The
Autor:
Christopher Hong, Layton Lamsam, Anna Crawford, Kevin N. Sheth, Ryan Rimmer, Sacit Bulent Omay
Publikováno v:
32nd Annual Meeting North American Skull Base Society.
Publikováno v:
Expert opinion on drug delivery.
Traumatic brain injuries (TBIs) impact the breadth of society and remain without any approved pharmacological treatments. Despite successful Phase II clinical trials, the failure of many Phase III clinical trials may be explained by insufficient drug